Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
115,403,935
-
Share change
-
-4,891,455
-
Total reported value
-
$1,244,889,623
-
Put/Call ratio
-
45%
-
Price per share
-
$10.79
-
Number of holders
-
149
-
Value change
-
-$30,832,609
-
Number of buys
-
70
-
Number of sells
-
66
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q4 2015
As of 31 Dec 2015,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,403,935 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., FMR LLC, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Fund Advisors, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
149
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.